The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo, the WHO said Tuesday.

Two drugs are being trialled in the Ituri region in a programme set up just six weeks after the outbreak was declared, with hopes it will reduce mortality rates

The Democratic Republic of the Congo has launched a record-breaking trial for two drugs, enrolling patients just six weeks after an outbreak was declared in the Ituri region.